CellGENTherapies is the GMP-unit of the University Hospital of Ghent Belgium. At CellGENTherapies, we specialize in the manufacturing of cell and gene therapies for early phase clinical trials.
Our mission is to bring research “from bench to bedside” by offering academic and industry partners small-scale production of RNA vaccines and ATMPs for early clinical trials, for both off-the-shelf as well as for personalized medicine, in accordance with Good Manufacturing Practices (GMP). Next to manufacturing, we offer complementary high value services as IMPD writing, quality testing as well as technology transfer.
Company Details
- Employees
- 2
- Address
- Corneel Heymanslaan 10, 9000 Ghent,east-Flanders 9000,belgium
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://gmp-unit.be/
- Keywords
- as IMPD writing.
- HQ
- 9000 Ghent, East-Flanders
Cellgentherapies Questions
Cellgentherapies's website is https://gmp-unit.be/
Cellgentherapies's LinkedIn profile is https://be.linkedin.com/company/cellgentherapies
Cellgentherapies has
2 employees.
View email and phone details for 2
employees at Cellgentherapies.
Cellgentherapies's industry is
Pharmaceutical Manufacturing
Cellgentherapies's top competitors are
Cancer Research @ucc,
Ku Leuven Kulak,
Phanov,
Bcfi / Cbip,
Bpcrn,
Eu Biotech Campus,
Nanospresso-Nl,
Torpedo Bio,
Projipharm Ingenierie,
Gate Advanced Therapies And Tissue Engineering.
Cellgentherapies's categories are Pharmaceutical Manufacturing
